Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Medicine, Prostate cancer, Hazard ratio, PARP inhibitor, Oncology, and Olaparib.
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer
Differential Activity of PARP Inhibitors in<i>BRCA1</i>- Versus<i>BRCA2</i>-Altered Metastatic Castration-Resistant Prostate Cancer
Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations